This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.
Mohd. Wasiullah,
Piyush Yadav,
Aman Kumar Yadav,
- Principal, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Head, Department of Pharma: Chemistry, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Scholar, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
Abstract
The development, production, and safety monitoring of pharmaceuticals are being revolutionized by incorporating digital technologies. Throughout drug lifecycles, pharmaceutical software which includes cloud-based systems, automation, data analytics, and artificial intelligence (AI) has emerged behind efficiency and innovation. Real-time monitoring, predictive maintenance, and process optimization are made possible in manufacturing by software tools like Digital Twins, Manufacturing Execution Systems (MES), and Quality Management Systems (QMS). These technologies improve batch consistency, lower production costs and schedules, and increase adherence to Good Manufacturing Practice (GMP) standards. Pharmaceutical software is essential for post-market surveillance and pharmacovigilance in addition to manufacturing. Platforms for data integration and analytics driven by AI compile data from patient databases, electronic health records, and clinical trials to increase accuracy of regulatory reporting and identify adverse drug reactions sooner. By guaranteeing quicker access to high-quality medications, promoting individualized treatment plans, and boosting patient confidence in medication safety, these innovations are reshaping patient pathways. The pharmaceutical industry’s digital transformation is still accelerating in spite of obstacles like data security, high implementation costs, and interoperability. Pharmaceutical software will continue to be crucial in promoting a safer, more open, and patient-centered healthcare ecosystem as the sector shifts toward increased automation and connectivity
Keywords: Digital transformation, Drug manufacturing, Patient pathways, Pharmaceutical software, Safety monitoring
Mohd. Wasiullah, Piyush Yadav, Aman Kumar Yadav. A Review on Transforming Patient Pathways: The Impact of Pharmaceutical Software on Drug Manufacturing and Safety Monitoring. Emerging Trends in Personalized Medicines. 2026; 03(01):-.
Mohd. Wasiullah, Piyush Yadav, Aman Kumar Yadav. A Review on Transforming Patient Pathways: The Impact of Pharmaceutical Software on Drug Manufacturing and Safety Monitoring. Emerging Trends in Personalized Medicines. 2026; 03(01):-. Available from: https://journals.stmjournals.com/etpm/article=2026/view=238567
References
- Desai Artificial intelligence in pharmacovigilance: opportunities and challenges. Perspect Clin Res. 2024;15(3):116–21.
- Wasiullah M, Yadav P, Yadav SK, Chauhan Artificial intelligence in pharmacovigilance: improving drug safety. Res Rev J Comput Biol. 2025;14(1):1–10.
- Kirankumar D. AI-powered pharmacovigilance: revolutionizing adverse drug reaction detection, reporting, and future perspectives. Res Rev J Pharmacol. 2025;15(3):1–12.
- Jha A. Navigating the future of pharmacovigilance with hyperautomation. WNS Perspect. 2024 Nov 15.
- Markarian Trends in digitalization of pharmaceutical manufacturing. Pharm Technol Equip Process Rep. 2021 May 17.
- Eschbach Leading successful digital change by putting people first. Am Pharm Rev. 2024;27(6):65–67.
- Ullagaddi Digital transformation in the pharmaceutical industry: enhancing quality management systems and regulatory compliance. Int J Health Sci. 2024;12(1):31–43.
- Ogadah CO, Nweke IP, Koshechkin K, Onyeka VO, Hassan A, Olajuwon KB, et al. Digital transformation in pharmaceutical operations: a comprehensive review of Industrial Internet of Things applications. Asian J Res Med Pharm Sci. 2025;14(3):1–17.
- Garg AP. Drug safety and pharmacovigilance: the shift to autonomous, resilient, and efficient operations. Biomed J Sci Tech Res. 2025;61(2):1–6.
- Parrish M. Product focus: digital integration – new business management solutions offer end-to- end manufacturing connections. Pharm Manuf. 2019 Mar 28.
- Rokos A foundation for pharma’s digital transformation. Pharm Manuf. 2024 Jan 16.
- Markarian J. Embracing the digital factory for bio/pharma manufacturing. Pharm Technol. 2019;43(3).
- DasSarkar Pharma software: a complete overview. Int J Sci Healthc Res. 2023;8(2):1–8.
- Wu J, Zheng X, Madlena M, Kyritsis A semantic-driven approach for maintenance digitalization in the pharmaceutical industry. arXiv preprint. 2023.
- Ramanamuni S. Digital transformation: a critical component for CDMOs in the pharmaceutical Int J Sci Technol (IJSAT). 2024;9(1):1–7.
- Veeva How digital quality management is transforming pharma manufacturing. Available from: Veeva Website.
- Digital transformation: developing a fully automated pharma manufacturing facility. Pharm Eng. 2025;45(1):1–9.
- Chauhan Pharmacovigilance: a drug safety monitoring tool. J Pharmacovigil Drug Res. 2021;2(3–4). doi:10.53411/jpadr.2021.2.3.4.
- Pilipiec P, Liwicki M, Bota Using machine learning for pharmacovigilance: a systematic review. Pharmaceutics. 2022;14(2):266. doi:10.3390/pharmaceutics14020266.
- Kumar Emerging digital technologies for pharmaceutical drug traceability. Univ J Pharm Pharmacol. 2023. doi:10.31586/ujpp.2023.794.
Emerging Trends in Personalized Medicines
| Volume | 03 |
| 01 | |
| Received | 08/01/2026 |
| Accepted | 22/01/2026 |
| Published | 31/01/2026 |
| Publication Time | 23 Days |
Login
PlumX Metrics